ES507761A0 - Procedimiento para la preparacion de nuevas pirimidinonas . - Google Patents

Procedimiento para la preparacion de nuevas pirimidinonas .

Info

Publication number
ES507761A0
ES507761A0 ES507761A ES507761A ES507761A0 ES 507761 A0 ES507761 A0 ES 507761A0 ES 507761 A ES507761 A ES 507761A ES 507761 A ES507761 A ES 507761A ES 507761 A0 ES507761 A0 ES 507761A0
Authority
ES
Spain
Prior art keywords
pyrimidinones
procedure
preparation
new
new pyrimidinones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES507761A
Other languages
English (en)
Other versions
ES8207156A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19803046871 external-priority patent/DE3046871A1/de
Priority claimed from DE19813115447 external-priority patent/DE3115447A1/de
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of ES8207156A1 publication Critical patent/ES8207156A1/es
Publication of ES507761A0 publication Critical patent/ES507761A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES507761A 1980-12-12 1981-12-07 Procedimiento para la preparacion de nuevas pirimidinonas . Granted ES507761A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19803046871 DE3046871A1 (de) 1980-12-12 1980-12-12 Neue chinazolinone, ihre herstellung und ihre verwendung als arzneimittel
DE19813115447 DE3115447A1 (de) 1981-04-16 1981-04-16 Neue pyrimidinone, ihre herstellung und ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
ES8207156A1 ES8207156A1 (es) 1982-09-01
ES507761A0 true ES507761A0 (es) 1982-09-01

Family

ID=25789685

Family Applications (2)

Application Number Title Priority Date Filing Date
ES507761A Granted ES507761A0 (es) 1980-12-12 1981-12-07 Procedimiento para la preparacion de nuevas pirimidinonas .
ES82511835A Granted ES511835A0 (es) 1980-12-12 1982-04-30 "procedimiento para la preparacion de nuevas piriimidinonas".

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES82511835A Granted ES511835A0 (es) 1980-12-12 1982-04-30 "procedimiento para la preparacion de nuevas piriimidinonas".

Country Status (22)

Country Link
US (1) US4379788A (es)
EP (1) EP0054132B1 (es)
AR (1) AR227567A1 (es)
AU (1) AU543568B2 (es)
CA (1) CA1217767A (es)
CS (1) CS227024B2 (es)
DD (1) DD208151A5 (es)
DE (1) DE3166627D1 (es)
DK (1) DK525481A (es)
ES (2) ES507761A0 (es)
FI (1) FI813971L (es)
GB (1) GB2090249B (es)
GR (1) GR76952B (es)
HU (1) HU187384B (es)
IL (1) IL64504A (es)
MY (1) MY8700562A (es)
NO (1) NO814239L (es)
NZ (1) NZ199254A (es)
PH (1) PH18930A (es)
PL (1) PL135330B1 (es)
PT (1) PT74116B (es)
SU (1) SU1056900A3 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460589A (en) * 1980-10-03 1984-07-17 The Upjohn Company Process for treating hypertension
US4379778A (en) * 1980-10-10 1983-04-12 Air Products And Chemicals, Inc. Hydrogen peroxide synthesis
DE3428476A1 (de) * 1984-08-02 1986-02-13 Basf Ag, 6700 Ludwigshafen 4h-pyrido(2,3-d)(1,3)oxazin-4-on-derivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
DE3631294A1 (de) * 1986-09-13 1988-03-24 Thomae Gmbh Dr K Neue synergistische kombination bestehend aus einem phosphodiesterase-hemmer und einem thromboxan-a(pfeil abwaerts)2(pfeil abwaerts)-antagonisten und deren verwendung bzw. herstellung
US5037980A (en) * 1988-04-18 1991-08-06 American Cyanamid Company Phenyl imidazo[1,2-a]pyrimidines
GB8928346D0 (en) * 1989-12-15 1990-02-21 Smith Kline French Lab Chemical compounds
GB9126260D0 (en) * 1991-12-11 1992-02-12 Pfizer Ltd Therapeutic agents
GB9404485D0 (en) * 1994-03-09 1994-04-20 Cancer Res Campaign Tech Benzamide analogues
HU230154B1 (hu) 1997-11-12 2015-09-28 Bayer Intellectual Property Gmbh Eljárás 2-es helyzetben fenil-szubszituenst hordozó imidazo-triazinon-származékok előállítására
AU2645299A (en) * 1998-11-18 2000-06-05 Elena Alexandrovna Izaxon 6-(3-carboxymethylphenyl)-aminouracyl having a biological activity
US20040102324A1 (en) 2002-02-28 2004-05-27 Annis Gary David Heterocyclic diamide invertebrate pest control agents
US6642244B2 (en) 2001-03-16 2003-11-04 Bristol-Myers Squibb Co. Pyrazolopyridopyrimidine inhibitors of cGMP phosphodiesterase
AU2002257195A1 (en) * 2001-04-23 2002-11-05 University Of Virginia Patent Foundation Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
JP4540295B2 (ja) * 2001-05-09 2010-09-08 バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト ２−フェニル置換イミダゾトリアジノンの新しい用途
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
JP2007517071A (ja) * 2003-12-19 2007-06-28 メルク　エンド　カムパニー　インコーポレーテッド 有糸分裂キネシン阻害剤
SE0401345D0 (sv) * 2004-05-25 2004-05-25 Astrazeneca Ab Therapeutic compounds: Pyridine as scaffold
SE0401342D0 (sv) * 2004-05-25 2004-05-25 Astrazeneca Ab Therapeutic compounds
AU2005247808B2 (en) * 2004-05-31 2011-02-10 Msd K.K. Quinazoline derivative
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
SG166106A1 (en) * 2005-09-29 2010-11-29 Bayer Schering Pharma Ag Pde inhibitors and combinations thereof for the treatment of urological disorders
WO2008041118A2 (en) * 2006-10-04 2008-04-10 Pfizer Products Inc. Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
WO2008151734A1 (en) * 2007-06-13 2008-12-18 Bayer Schering Pharma Aktiengesellschaft Pde inhibitors for the treatment of hearing impairment
CN101531638B (zh) * 2008-03-13 2011-12-28 中国科学院广州生物医药与健康研究院 用作雌激素相关受体调节剂的化合物及其应用
US20110124634A1 (en) * 2008-05-13 2011-05-26 Poniard Pharmaceuticals, Inc. Bioactive compounds for treatment of cancer and neurodegenerative diseases
CN101628913B (zh) 2008-07-18 2013-01-23 中国科学院广州生物医药与健康研究院 用作雌激素相关受体调节剂的化合物及其应用
SG11201502120XA (en) 2012-09-26 2015-04-29 Merck Patent Gmbh Quinazolinone derivatives as parp inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3265697A (en) * 1964-09-04 1966-08-09 Shulton Inc 2-p-dialkylaminoalkoxyphenyl-2, 3-dihydro-4 (1h)-quinazolinones and their derivatives
DE1939109A1 (de) * 1968-08-31 1970-03-05 Troponwerke Dinklage & Co 2-Methyl-3-[2-(2-diaethylaminoaethoxy)-phenyl]-chinazolinon-(4) und Verfahren zu seiner Herstellung
US3862191A (en) * 1972-09-27 1975-01-21 Pfizer Pyrido{8 2,3-d{9 pyrimidin-4(3H)-one

Also Published As

Publication number Publication date
GB2090249B (en) 1984-08-22
SU1056900A3 (ru) 1983-11-23
CA1217767A (en) 1987-02-10
IL64504A0 (en) 1982-03-31
HU187384B (en) 1985-12-28
AU543568B2 (en) 1985-04-26
US4379788A (en) 1983-04-12
DK525481A (da) 1982-06-13
AR227567A1 (es) 1982-11-15
PT74116B (de) 1983-12-19
PH18930A (en) 1985-11-11
PL234175A1 (es) 1982-08-16
EP0054132A1 (de) 1982-06-23
ES8304096A1 (es) 1983-02-16
EP0054132B1 (de) 1984-10-10
DD208151A5 (de) 1984-03-28
GR76952B (es) 1984-09-04
NZ199254A (en) 1985-02-28
DE3166627D1 (en) 1984-11-15
AU7847381A (en) 1982-06-17
MY8700562A (en) 1987-12-31
FI813971L (fi) 1982-06-13
IL64504A (en) 1985-02-28
NO814239L (no) 1982-06-14
ES8207156A1 (es) 1982-09-01
PL135330B1 (en) 1985-10-31
ES511835A0 (es) 1983-02-16
GB2090249A (en) 1982-07-07
PT74116A (de) 1982-01-01
CS227024B2 (en) 1984-04-16

Similar Documents

Publication Publication Date Title
ES507761A0 (es) Procedimiento para la preparacion de nuevas pirimidinonas .
ES517167A0 (es) Procedimiento para la preparacion de nuevos bencimidazoles sustituidos.
ES516368A0 (es) Procedimiento para la obtencion de fenoxifenil-azol-metilcetonas y-carbinoles.
ES505472A0 (es) Procedimiento para la preparacion de compuestos frugicidas.
ES521871A0 (es) Procedimiento para la preparacion de nuevos benzo-heterociclos.
ES507667A0 (es) Procedimiento para la preparacion de 8-arilalcohil-3-fenil-3-nortropanoles .
ES504791A0 (es) Procedimiento para la preparacion de derivados de caprolactama.
ES507307A0 (es) Procedimiento para la determinacion de colesterina.
ES507635A0 (es) Procedimiento para la preparacion de nuevas fenilalcohilaminas .
ES513792A0 (es) Procedimiento para la preparacion de amidobenzamidas.
ES520579A0 (es) Procedimiento para la preparacion de eteres oximicos.
ES507015A0 (es) Procedimiento para la preparacion de nuevas indolinonas.
ES515139A0 (es) Procedimiento para la obtencion de anilinometilen-oximas sustituidas.
ES507468A0 (es) Procedimiento para la preparacion de acilureas.
ES519529A0 (es) Procedimiento para la preparacion de nuevas tienobenzodiazepinonas sustituidas.
ES518272A0 (es) Procedimiento para la preparacion de derivados de tiazolina.
ES513476A0 (es) Procedimiento para la obtencion de fenoxipropionatos sustituidos.
ES502212A0 (es) Procedimiento para la preparacion de n-di-n-propil-2,6-dini-tro-4-trifluorometilanilina
ES517153A0 (es) Procedimiento para la preparacion de nuevas acinorrifamicinas.
ES520706A0 (es) Procedimiento para la preparacion de sulfonilureas.
ES513169A0 (es) Procedimiento para la obtencion de nuevos derivados de benzazol.
ES521979A0 (es) Procedimiento para la preparacion de disulfuros.
ES500071A0 (es) Procedimiento para la preparacion de nuevos 2-nitro-5-feno- xifenil-oxazoles,-oxacinas,-imidazoles,-pirimidinas o-tiazo-les
AR228051A1 (es) Procedimiento para la preparacion de nuevos 2-piperidino-4-amino-6,7-dimetoxiquinazolinas sustituidas
ES517888A0 (es) Procedimiento para la preparacion de tioalcanoil-carnitinas.